Research Jessica Kean 10/10/23 Research Jessica Kean 10/10/23 FDA's ODAC Votes in Favor of Drug to Reduce Neuroblastoma Relapse Risk Read More Programs Jessica Kean 3/3/22 Programs Jessica Kean 3/3/22 A New FDA-Approved Patient-Focused Drug Development Meeting on Reducing Cardiac Late Effects Read More Policy Steve Wosahla 7/12/21 Policy Steve Wosahla 7/12/21 Call For More FDA Resources Included in New House Appropriations Bill Read More Research Jessica Kean 1/15/21 Research Jessica Kean 1/15/21 FDA Approves Crizotinib for Treatment of Rare Lymphoma in Children Read More Policy Jessica Kean 8/18/20 Policy Jessica Kean 8/18/20 The RACE for Children Act Now in Full Effect Read More Policy Jessica Kean 12/11/19 Policy Jessica Kean 12/11/19 Taking Action to Reduce Drug Shortages Read More Older Posts
Research Jessica Kean 10/10/23 Research Jessica Kean 10/10/23 FDA's ODAC Votes in Favor of Drug to Reduce Neuroblastoma Relapse Risk Read More
Programs Jessica Kean 3/3/22 Programs Jessica Kean 3/3/22 A New FDA-Approved Patient-Focused Drug Development Meeting on Reducing Cardiac Late Effects Read More
Policy Steve Wosahla 7/12/21 Policy Steve Wosahla 7/12/21 Call For More FDA Resources Included in New House Appropriations Bill Read More
Research Jessica Kean 1/15/21 Research Jessica Kean 1/15/21 FDA Approves Crizotinib for Treatment of Rare Lymphoma in Children Read More
Policy Jessica Kean 8/18/20 Policy Jessica Kean 8/18/20 The RACE for Children Act Now in Full Effect Read More
Policy Jessica Kean 12/11/19 Policy Jessica Kean 12/11/19 Taking Action to Reduce Drug Shortages Read More
